Physician

Sabin Dang, MD

According to 2025 Medicare claims, Sabin Dang, MD (NPI: 1740579531) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LLC (NPI: 1700175395; TIN: 430913832) and primary practice location at 62034-1702.

Dang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 913 traditional Medicare patients, billed 38,259 HCPCS/CPT codes, and received $2,134,330 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 741 prescription claims across 246 beneficiaries totaling $40,130 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 80 records totaling $74,609. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $13,936 to $2,134,330. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $11,210 to $40,130. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2015 Medicare payment: $13,936 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $26,457 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $354,376 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,194,322 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,377,793 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,216,823 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,599,534 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,670,920 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,976,197 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,134,330 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156196$13,936
2016151196$26,457
20176073,005$354,376
20181,0528,796$1,194,322
20191,1499,919$1,377,793
20201,1419,291$1,216,823
20211,42412,093$1,599,534
20221,21510,668$1,670,920
202395820,476$1,976,197
202491338,259$2,134,330

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$49K2015 Drug cost: $11,210 (USD; Tot_Drug_Cst)2016 Drug cost: $8,726 (USD; Tot_Drug_Cst)2017 Drug cost: $11,673 (USD; Tot_Drug_Cst)2018 Drug cost: $27,969 (USD; Tot_Drug_Cst)2019 Drug cost: $37,979 (USD; Tot_Drug_Cst)2020 Drug cost: $33,749 (USD; Tot_Drug_Cst)2021 Drug cost: $42,210 (USD; Tot_Drug_Cst)2022 Drug cost: $48,857 (USD; Tot_Drug_Cst)2023 Drug cost: $41,184 (USD; Tot_Drug_Cst)2024 Drug cost: $40,130 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201564307$11,210
201660139$8,726
201785223$11,673
2018162497$27,969
2019208615$37,979
2020169578$33,749
2021232733$42,210
2022222740$48,857
2023224767$41,184
2024246741$40,130

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3111,125$91
92014Established patient complete exam of visual system615924$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more314655$68
92134Imaging of retina8722,626$30
92202Extended exam of the back part of the eye with optic nerve drawing587979$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium341,425$11,960
Prednisolone AcetatePrednisolone Acetate1796,241$6,742
Bromfenac SodiumBromfenac Sodium461,319$6,537
Lotemax SmLoteprednol Etabonate17441$4,230
OfloxacinOfloxacin1202,699$1,171

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.73$57,123Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.7$17,486Bausch & Lomb Americas Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sabin Dang, MD?

Tedicare shows public-source Medicare data for Sabin Dang, MD (NPI 1740579531), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sabin Dang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sabin Dang, MD?

Sabin Dang, MD is linked to RETINA CONSULTANTS, LLC (billing NPI 1700175395) in the available physician profile data.

Does Sabin Dang, MD have Open Payments data?

Sabin Dang, MD has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.